Prevalence and interannual changes in multiple chemical sensitivity in Japanese workers

Abstract

Objective

We aimed to evaluate the prevalence rates and interannual fluctuations in multiple chemical sensitivity (MCS) in Japanese workers.

Methods

We assessed MCS using the Quick Environmental Exposure and Sensitivity Inventory, employing both Miller and Japanese criteria. Workers of two manufacturing companies located in Kyushu, Japan, were assessed, with company A surveyed in 2003, 2006 and 2011, and company B in 2003 and 2011.

Results

In company A, the Miller criteria-based MCS prevalence rate was higher in 2011 than in 2003, and according to the Japanese criteria, it was higher in 2011 than 2006. In company B, the Miller criteria-based MCS prevalence rate was lower in 2011 than in 2003.

Conclusion

The results indicated that MCS exists among industrial workers in Japan. We found no statistically significant interannual changes in MCS rates.

Introduction

Multiple chemical sensitivity (MCS) is an acquired chronic disorder in which exposure to low levels of chemicals causes mild to wholly disabling symptoms [1]. Symptoms are usually vague and nonspecific, involving more than one organ system. In general, the reported symptoms are attributed to previous chemical exposure, and recur on subsequent exposure to chemicals at doses below those known to cause harmful effects in the general population [2]. The etiology of MCS, however, remains unclear. It is difficult to estimate its prevalence because it is derived from self-reports, which differ from case rates diagnosed by medical staff—occupational physicians in particular [1]. MCS patients’ clinical characteristics are usually evaluated using questionnaires such as the Environmental Exposure and Sensitivity Inventory (EESI), or clinical interviews that rely on the individual’s retrospective self-reports [3]. Miller and Prihoda [4] developed a globally standardized self-administered questionnaire, the Quick Environmental Exposure Sensitivity Inventory (QEESI), designed to assist researchers and clinicians in screening, studying, and evaluating patients with MCS.

People with environmental sensitivities may be susceptible to diverse environmental factors. Some of the more common agents containing chemical compounds that trigger reactions in such people include pesticides and volatile organic compounds (VOCs), such as solvents, perfumes, formaldehyde, and other petrochemicals. These agents may be contained in workplace building structures, furnishings, and cleaning products, among other sources [5]. A definition of work-related MCS was introduced by Cullen [6]. Adverse MCS health effects were observed in workers in subsequent research [7]; the negative effects of chemical hazards are a longstanding part of occupational health in the industrialized world [8]. While such issues initially tended to arise in industrial workers, similar problems have emerged in residents and workers in tight buildings in air- and water-polluted communities, and in persons exposed to various chemicals [9]. We selected workers employed in two large companies as participants, because this group allowed for easier follow-ups than community residents. The response rate may be higher from the workers who answered the questionnaires as instructed by company leaders. In addition to our aim of evaluating MCS prevalence rates and their interannual change, we assessed the rates of allergies and Sick house syndrome (SHS) in Japanese workers.

Materials and methods

Study characteristics

The present study was carried out at a paper pulp producing company (company A) in 2003, 2006, and 2011, and at an automotive company (company B) in 2003 and 2011, both in Kyushu, Japan. Subjects were asked to complete QEESI questionnaires, which also cover the respondents’ diagnostic history of allergies and SHS. After excluding invalid questionnaires, we obtained 832 valid responses in 2003, 729 in 2006, and 144 in 2011 at company A, and 333 responses in 2003 and 426 in 2011 at company B.

Survey instruments

We used the Japanese version of the QEESI questionnaire prepared by Ishikawa and Miyata to assess MCS [10]. Each criterion subscale of the QEESI contains 10 questions rated on a scale from 0 to 10; the total possible score for each subscale, therefore, ranges from 0 to 100.

We used the Miller criteria to define MCS in workers according to the scores yielded by three cut-off subscales: ≥40 for chemical sensitivity, ≥25 for other chemicals, and ≥40 for symptom severity classified as MCS [4]. Hojo et al. [11] designed a study to establish the cut-off value for Japanese criteria using the QEESI as an MCS screening method. We also employed their Japanese criteria of ≥40 for chemical sensitivity, ≥20 for symptom severity, and ≥10 for life impact classified as MCS.

Data analysis

We collected and used anonymous information for data analysis. The distribution differences were examined using Chi square test. The average differences were examined using t tests. Statistical analyses were carried out using SPSS version 18 for Windows (SPSS, Japan).

Ethical statement

The ethics review boards of Miyazaki University (no. 82; April 9, 2003) and Kumamoto University (no. 168; May 11, 2011) approved this study, following their ethical guidelines for human research. All participants provided written informed consent to participate, and the complete protection of their personal data was agreed upon in writing.

Results

At the 2003 baseline, SHS diagnostic history rates for companies A and B were 0.1 and 0.3 %, respectively, and the allergy diagnostic history rates for companies A and B were 23.1 and 24.0 %, respectively (Tables 1, 2). The Miller-criteria-based MCS prevalence rate was 1.1 % in company A and 2.4 % in company B in 2003 (Figs. 1, 2).

Table 1 Diagnostic history and characteristics of respondents from company A

Table 2 Diagnostic history and characteristics of respondents from company B

Fig. 1

Interannual changes in company A employee MCS rates, diagnosed through the QEESI using the Miller criteria (3 overlap was considered multiple chemical sensitivity)

Fig. 2

Interannual changes in company B employee MCS rates, diagnosed through the QEESI using the Miller criteria (3 overlap was considered multiple chemical sensitivity)

In company A, SHS diagnostic history rate rose in 2011 (2.1 %) compared to 2003 and 2006 (0.1 %). The allergy diagnostic history rate decreased in 2006 (20.7 %) but rose in 2011 (39.6 %) (Table 1). In company B, the SHS and allergy diagnostic history rates (0.5 and 29.3 %, respectively) increased in 2011 (Table 2). In company A, the Miller-criteria-based MCS prevalence rate rose in 2011 (1.4 %) in comparison to 2003 and 2006 (1.1 %) (Fig. 1). However, in company B, Miller-criteria-based MCS prevalence rates dropped in 2011 (1.6 %) from 2003 (2.4 %) (Fig. 2).

As the life impact subscale was not employed in 2003, company A’s QEESI-derived Japanese criteria-based MCS prevalence rate could only be determined between 2006 and 2011 (Fig. 3). The Japanese criteria-based MCS prevalence rate increased in 2011 (4.2 %) from 2006 (3.3 %); these prevalence rates were higher than those derived from the Miller criteria in 2011 (1.4 %) and 2006 (1.1 %) (Fig. 1). Nevertheless, these differences were not statistically significant.

Fig. 3

Interannual changes in company A employee MCS rates, diagnosed through the QEESI using the Japanese criteria (3 overlap was considered multiple chemical sensitivity)

In addition, the mean age of company A employees rose in 2006 (44.9 ± 10.61 years old) and decreased in 2011 (41.5 ± 11.04 years old) compared to baseline (42.8 ± 10.34 years old). The proportion of women in company A in 2011 (16.7 %) grew from 2003 (11.7 %) to 2006 (10.0 %) (Table 1). The mean age of employees in company B increased in 2011 (44.8 ± 9.78 years old) when compared to 2003s baseline (40.5 ± 8.65 years old); the proportion of females also grew from 2003 (0 %) to 2011 (3.1 %) (Table 2).

Discussion

This study investigated both Miller and Japanese criteria-based MCS prevalence rates across several years in Japanese general industrial workers.

Miller and Prihoda American study indicated that the MCS rate was 7.1 % in 1999 [4]. A larger-scale investigation by Kreutzer et al. [12] employed a telephone survey, and found MCS rates of 6.3 %. In line with the present findings, studies by Uchiyama in 2000 and by Hojo in 2002 showed Japan’s MCS rate to be lower than that of the USA [13, 14]. In both companies, allergy diagnostic history rates rose in 2011 compared to 2003. Our findings were consistent with the increasing trend of allergy epidemic in Japan [15].

In the work environment, Watanabe et al. [16] identified several at-risk categories of chemicals, especially volatile compounds such as organic solvents. Many compounds used daily in manufacturing processes contained such chemicals, and exposed not only the workers who produced them, but also those in areas such as construction, automotive work, textiles, cleaning, and so on [1]. The impact of environmental sensitivities on workers may range from mild to severe, even making work impossible in some cases [5]. However, as this study’s subjects were workers from two large companies, it is important to note the selection bias known as the healthy worker effect (HWE), the process wherein unhealthy individuals are excluded from the workplace, as healthy workers are more likely to continue to work than those who are sick [17]. Some studies have suggested that incomplete follow-ups with workers who leave employment and migrate away from their workplace could be a source of the HWE [18, 19]. Terr comments that some MCS patients change their jobs because of their symptoms [20], Lax and Henneberger later reported a similar conclusion [21]. A 2-year follow-up of 50 subjects with MCS showed that most were unchanged or worse by their final assessment [22]. Follow-up studies show that people with MCS frequently suffer symptoms for many years, but may show gradual improvement over time [16]. As the present study anonymized participants, it was impossible to confirm how many workers were continuously checked across several years. We also have found that it was impossible to follow-up with subjects who ceased working due to MCS. However, many patients were overlap in different years, which may indicate that they did not leave the workplace and were not recovered from MCS symptoms. The HWE may influence the MCS prevalence rate found in this study; however, this bias may not have had a significant impact on the results.

In occupational settings, exposures are often chronic. This suggests that controlling chemical exposure in the early phases of MCS may prevent more serious developments. Even for healthy people, numerous aggravating exposures may be below legal limits but not within adequate safety margins to prevent symptoms [23]. Improving environmental quality in the workplace can promote worker’s health and productivity. Such workplace accommodation may include behavior changes, including the use of the least toxic cleaning products and pest control practices, and avoidance of scented products [5]. Furthermore, comparing estimated onset factors between male and female patients revealed that workplace chemical exposure was markedly higher in males [24].